Health · Thursday, October 8, 2026
Lab-grown mini-lungs kept their own immune cells and fought a virus
The File desk · Oct 8, 2026, 10:45 AM UTC
Status
Confirmed from a National Institutes of Health news release dated Oct. 7, 2026. The Nature paper was not opened. Nothing here is a human trial.
Researchers at Stanford grew small pieces of human lung in the lab that keep their own immune cells for months, and those cells fought the virus that causes COVID-19. When the team first exposed the tissue to bits of the virus, much like a vaccine, later infections were weaker. The study, funded by the National Institutes of Health and published Wednesday in Nature, suggests the lung's own defenses may do a lot of the protecting. The models could also stand in for some tests that now use animals. This was not a trial in people.
The tissue came from more than 220 patient volunteers. The pieces lived for up to several months in a setup that mimics breathing, with air on one side and liquid on the other. The immune cells in the tissue were permanent residents, and they kept their ability to sense the virus.
Dr. John H. Powers III, acting director of the NIH institute for allergy and infectious diseases, said the platform may provide a replacement for animal models for some types of evaluations. Dr. Calvin Kuo of Stanford Medicine, the senior author, said the work unveiled indications that resident immune cells may be much more persistent than previously thought.
The authors think the work could support vaccines given directly to the lungs. That is their view, not a result in people. The paper is Rathkey and colleagues, “Human lung organoid modelling of tissue-resident antiviral T cell responses,” Nature, Oct. 7, 2026. This desk did not open it.
What is still unknown or disputed
- Whether any of this works as a vaccine in people. The study did not test one.
- What the full paper adds beyond the NIH release. The paper was not opened.
Primary sources
Every claim in this story is drawn from the documents below. If a fetch failed, that is recorded on the card.
Source 1
Human lung organoids with a built-in immune system could transform respiratory disease research
National Institutes of Health · October 7, 2026
In a National Institutes of Health (NIH)-supported study, researchers at the Stanford University School of Medicine elicited virus-specific immune responses from these organoids and showed that administering a virus booster weakened subsequent infections.
https://www.nih.gov/news-events/news-releases/human-lung-organoids-built-immune-system-could-transform-respiratory-disease-research